Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Can Peritoneal Dialysis Remove Endothelin-1 after Cardiopulmonary Bypass for Repair of Congenital Heart Disease?

체외순환을 이용한 선천성 심장수술 후에 시행한 복막투석이 내피의존성 혈관 활성 물질인 Endothelin-1을 제거할 수 있는가?

  • Chang, Yun-Hee (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Pusan National University) ;
  • Ban, Ji-Eun (Department of Pediatrics, College of Medicine, Pusan National University) ;
  • Lee, Hyoung-Doo (Department of Pediatrics, College of Medicine, Pusan National University) ;
  • Lee, Sun-Hee (Department of Pharmacology, College of Medicine, Pusan National University) ;
  • Rhym, Byuong-Yong (Department of Pharmacology, College of Medicine, Pusan National University) ;
  • Sung, Si-Chan (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Pusan National University)
  • 장윤희 (부산대학교 의과대학 흉부외과학교실) ;
  • 반지은 (부산대학교 의과대학 소아과학교실) ;
  • 이형두 (부산대학교 의과대학 소아과학교실) ;
  • 이선희 (부산대학교 의과대학 약리학교실) ;
  • 임병용 (부산대학교 의과대학 약리학교실) ;
  • 성시찬 (부산대학교 의과대학 흉부외과학교실)
  • Published : 2007.04.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Lung injury that follows bypass has been well described. It is manifested as reduced oxygenation and lung compliance and, most importantly, increased pulmonary vascular resistance reactivity; this is a known cause of morbidity and mortality after repair of congenital heart disease. Injury to the pulmonary vascular endothelium, and its associated alterations of endothelin-1, is considered to be a major factor of bypass-induced lung injury. Removing endothelin-1 after bypass may attenuate this response. This study measured the concentration of serum and peritoneal effluent endothelin-1 after performing bypass to determine if endothelin-1 can be removed via peritoneal dialysis. Material and Method: From March 2005 to March 2006, 18 patients were enrolled in this study Peritoneal catheters were placed at the end of surgery. Serum samples were obtained before and after bypass, and peritoneal effluents were obtained after bypass. Endothelin-1 was measured by enzyme linked immunosorbent assay (ELISA). Result: In the patients with a severe increase of the pulmonary artery pressure or flow, the mean preoperative plasma endothelin-1 concentration was significantly higher than that in the patients who were without an increase of their pulmonary artery pressure or flow (4.2 vs 1.8 pg/mL, respectively, p<0.001). The mean concentration of plasma endothelin-1 increased from a preoperative value of $3.61{\pm}2.17\;to\;5.33{\pm}3.72 pg/ml$ immediately after bypass. After peritoneal dialysis, the mean plasma endothelin-1 concentration started to decrease. Its concentration at 18 hours after bypass was significantly lower than the value obtained immediately after bypass (p=0.036). Conclusion: Our data showed that the plasma endothelin-1 concentration became persistently decreased after starting peritoneal dialysis, and this suggests that peritoneal dialysis can remove the circulating plasma endothelin-1.

배경: 일반적으로 선천성 심장질환의 수술교정에는 체외 심폐 순환(체외순환)이 이용된다. 체외순환과 관련된 폐손상이 잘 알려져 있는데, 임상적으로 산소화의 저하, 폐유순도의 감소, 폐혈관의 저항과 반응성의 증가의 소견을 보이며 수술 후 합병증 및 사망의 중요한 원인이 된다. 이러한 폐손상의 원인은 보체의 할성화, 호중구의 축적, 산소라디칼손상을 포함하여 아주 다양하지만, 폐혈관 내피의 손상과 그에 의한 endothelin-1 발현의 변화가 주된 원인이라고 보고되고 있다. 저자들은 복막 투석이 혈장 endothelin-1의 제거에 기여할 수 있는지 여부에 대한 연구를 하였다. 대상 및 방법: 2005년 3월 부터 2006년 3월 사이에 18명의 환자를 대상으로 하였다. 혈장 검체는 수술 전후로 채취하였고, 수술 후 복막 투석 카테터를 삽입하여 체외순환 이탈 후의 복막 유출액 검체를 채취하였다. Endothelin-1의 농도측정은 ELISA (enzyme Linked Immunosorbent assay)로 시행하였다. 결과: 술 전에 측정된 endothelin-1 값이 술 전 폐혈류 혹은 폐동맥압의 증가의 진단을 가진 환아에서 유의하게 높았다 (4.2 vs 1.8 pg/mL, p<0.001). 수술 전 혈장 endothelin-1의 평균 농도는 $3.61{\pm}2.17pg/mL$이었고, 체외순환 이탈 직후는 $5.33{\pm}3.72 pg/mL$로 가장 높게 측정되었다. 복막 투석 시작 후, 농도는 감소하기 시작하여 체외순환 이탈 직후에 비해 18시간째에는 유의하게 낮은 농도를 나타내었다(p=0.036). 결론: 혈장 endothelin-1 농도가 체외순환 이탈 직후에 가장 높게 측정되었고, 복막 투석 후 감소하기 시작하는 소견은 복막 투석으로 혈장 endothelin-1이 제거될 수 있는 가능성을 강하게 시사한다.

Keywords

References

  1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5 https://doi.org/10.1038/332411a0
  2. Pearl JM, Manning PB, McNamara JL, Saucier MM, Thomas DW. Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypass. Ann Thorac Surg 1999;68:1369-75 https://doi.org/10.1016/S0003-4975(99)00978-9
  3. Bokesch PM, Kapural MB, Mossad EB, et al. Do peritoneal catheters remove pro-inflammatory cytokines after cardiopulmonary bypass in neonates? Ann Thorac Surg 2000;70:639-43 https://doi.org/10.1016/S0003-4975(00)01453-3
  4. La M, Reid JJ. Endothelin-1 and the regulation of vascular tone. Clin Exp Pharmacol Physiol 1995;22:315-23 https://doi.org/10.1111/j.1440-1681.1995.tb02008.x
  5. Fagan KA, McMurtry IF, Rodman DM. Role of endothelin-1 in lung disease. Respir Res 2001;2:90-101 https://doi.org/10.1186/rr44
  6. Wong J, Vanderford PA, Winters J, Soifer SJ, Fineman JR. Endothelinb receptor agonists produce pulmonary vasodilation in intact newborn lambs with pulmonary hypertension. J Cardiovasc Pharmacol 1995;25:207-15 https://doi.org/10.1097/00005344-199502000-00005
  7. Wong J, Vanderford PA, Fineman JR, Soifer SJ. Developmental effects of endothelin-1 on the pulmonary circulation in sheep. Pediatr Res 1994;36:394-401 https://doi.org/10.1203/00006450-199409000-00021
  8. Ruwhof C, van der Laarse A. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc Res 2000;47:23-37 https://doi.org/10.1016/S0008-6363(00)00076-6
  9. Burrows FA, Klinck JR, Rabinovitch M, Bohn DJ. Pulmonary hypertension in children: perioperative management. Can Anaesth Soc J 1986;33:606-28 https://doi.org/10.1007/BF03014268
  10. Yoshibayashi M, Nishioka K, Nakao K, et al. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation 1991;84:2280-5 https://doi.org/10.1161/01.CIR.84.6.2280
  11. Ishikawa S, Miyauchi T, Ueno H, et al. Influence of pulmonary blood pressure and flow on endothelin-1 production in humans. J Cardiovasc Pharmacol 1995;26(Suppl 3):S429-33 https://doi.org/10.1097/00005344-199506263-00126
  12. Wheller J, George BL, Mulder DG, Jarmakani JM. Diagnosis and management of postoperative pulmonary hypertensive crisis. Circulation 1979;60:1640-4 https://doi.org/10.1161/01.CIR.60.7.1640
  13. Dschietzig T, Richter C, Bartsch C, et al. Flow-induced pressure differentially regulates endothelin-1, urotensin II, adrenomedullin, and relaxin in pulmonary vascular endothelium. Biochem Biophys Res Commun 2001;289:245-51 https://doi.org/10.1006/bbrc.2001.5946
  14. Reddy VM, Meyrick B, Wong J, et al. In utero placement of aortopulmonary shunts. A model of postnatal pulmonary hypertension with increased pulmonary blood flow in lambs. Circulation 1995;92:606-13 https://doi.org/10.1161/01.CIR.92.3.606
  15. Ovadia B, Reinhartz O, Fitzgerald R, et al. Alterations in ET-1, not nitric oxide, in 1-week-old lambs with increased pulmonary blood flow. Am J Physiol Heart Circ Physiol 2003;284:H480-90 https://doi.org/10.1152/ajpheart.00493.2002
  16. Black SM, Bekker JM, Johengen MJ, Parry AJ, Soifer SJ, Fineman JR. Altered regulation of the ET-1 cascade in lambs with increased pulmonary blood flow and pulmonary hypertension. Pediatr Res 2000;47:97-106 https://doi.org/10.1203/00006450-200001000-00018
  17. Black SM, Mata-Greenwood E, Dettman RW, et al. Emergence of smooth muscle cell endothelin B-mediated vasoconstriction in lambs with experimental congenital heart disease and increased pulmonary blood flow. Circulation 2003;108:1646-54 https://doi.org/10.1161/01.CIR.0000093723.57673.9F
  18. Shafique T, Johnson RG, Dai HB, Weintraub RM, Sellke FW. Altered pulmonary microvascular reactivity after total cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;106:479-86
  19. Pearl JM, Wellmann SA, McNamara JL, et al. Bosentan prevents hypoxia-reoxygenation-induced pulmonary hypertension and improves pulmonary function. Ann Thorac Surg 1999;68:1714-21 https://doi.org/10.1016/S0003-4975(99)00988-1
  20. Carteaux JP, Roux S, Siaghy M, et al. Acute pulmonary hypertension after cardiopulmonary bypass in pig: the role of endogenous endothelin. Eur J Cardiothorac Surg 1999;15:346-52 https://doi.org/10.1016/S1010-7940(99)00017-2
  21. Komai H, Adatia IT, Elliott MJ, de Leval MR, Haworth SG. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease. J Thorac Cardiovasc Surg 1993;106:473-8
  22. Pernow J, Wang QD. Endothelin in myocardial ischaemia and reperfusion. Cardiovasc Res 1997;33:518-26 https://doi.org/10.1016/S0008-6363(96)00265-9
  23. Takanashi M, Endoh M. Characterization of positive inotropic effect of endothelin on mammalian ventricular myocardium. Am J Physiol 1991;261:H611-9
  24. Petrossian E, Parry AJ, Reddy VM, et al. Endothelin receptor blockade prevents the rise in pulmonary vascular resistance after cardiopulmonary bypass in lambs with increased pulmonary blood flow. J Thorac Cardiovasc Surg 1999;117:314-23 https://doi.org/10.1016/S0022-5223(99)70429-0
  25. Reddy VM, Hendricks-Munoz KD, Rajasinghe HA, Petrossian E, Hanley FL, Fineman JR. Post-cardiopulmonary bypass pulmonary hypertension in lambs with increased pulmonary blood flow. A role for endothelin 1. Circulation 1997;95:1054-61 https://doi.org/10.1161/01.CIR.95.4.1054
  26. Miyauchi T, Yorikane R, Sakai S, et al. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res 1993;73:887-97 https://doi.org/10.1161/01.RES.73.5.887
  27. Schulz-Neick I, Li J, Reader JA, Shekerdemian L, Redington AN, Penny DJ. The endothelin antagonist BQ 123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease. J Thorac Cardiovasc Surg 2002;124:435-41 https://doi.org/10.1067/mtc.2002.121492
  28. Hiramatsu T, Imai Y, Takanashi Y, et al. Time course of endothelin-1 and nitrate anion levels after cardiopulmonary bypass in congenital heart defects. Ann Thorac Surg 1997;63:648-52 https://doi.org/10.1016/S0003-4975(96)01055-7